# DDLPS_doxorubicin_NHEJ_R
Source code regarding the manuscript: Targeting the Non-Homologous End-Joining Pathway Sensitizes MDM2-Amplified Liposarcoma to Doxorubicin-Induced Senescence in a p53-dependent Manner
